NVS : Analysis & Opinions

  1. Canada Wants Painkiller Warnings as Deaths Soar

    January 23, 2017
    Amid rising painkiller-related deaths, Canada wants to use cigarette-style warning stickers.
  2. Mallinckrodt Fined $100M For Antitrust Violations

    January 23, 2017
    Mallinckrodt will pay $100 million to settle antitrust violations following an FTC investigation.
  3. These 5 Drug Patents Will Expire in 2017

    January 16, 2017
    Investopedia looks at the top drug patents about to expire in 2017
  4. Are M&A Rumors Driving Intercept Pharma's Stock?

    January 5, 2017
    Takeover rumors have fueled huge fluctuations in Intercept Pharmaceuticals shares.
  5. Ophthotech Plunges After Eye Drug Fails Phase 3

    December 12, 2016
    A drug combo study using Ophthotech's Fovista eye drug failed a mid-stage clinical trial.
  6. Novartis Lung Cancer Drug Beats Chemo in Study

    December 8, 2016
    Novartis said its Zykadia drug was twice as effective against chemotherapy in a Phase 3 trial.
  7. Novartis, Kite Race for Next-Gen Cancer Drug (NVS, KITE)

    December 5, 2016
    Rivals Kite and Novartis are both racing to market their leukemia drug first.
  8. How China Makes Money (BABA, PFE)

    December 2, 2016
    China has the first or second largest GDP in the world but is not nearly as developed as others in the top 10.
  9. Novartis Launches Heart Failure Network (NVS)

    November 25, 2016
    Norvartis' launch of a heart-failure social network offers a win-win for patients, caregivers and the company.
  10. Novartis Buys Sickle Cell Drug Maker for $665M (NVS)

    November 22, 2016
    The purchase of Selexys Pharmaceuticals will augment Novartis’ hematology product pipeline with a new promising sickle cell ...
  11. Google, Novartis Delay Smart Lens (NVS, GOOGL)

    November 22, 2016
    Novartis has delayed human trials of the "smart" contact lenses it's developing with Google.
  12. Drug Makers Sued for Price Collusion (NVS, TEVA)

    November 20, 2016
    Novartis, Teva, Akorn and other drug makers are being sued by NYPD unions for alleged price collusion on their skin creams.
  13. Big Pharma Battles over Psoriasis Market (NVS, CELG)

    November 17, 2016
    Major drug makers are battling for dominance of the lucrative psoriatic arthritis drug space.
  14. Novartis Leukemia Drug Expedited by FDA (NVS)

    November 16, 2016
    Novartis' leukemia drug was approved for FDA priority review, which means it could reviewed in 6 months.
  15. Novartis Eyes $8B Buy of Generic Drug Firm (NVS)

    November 15, 2016
    The potential $8 billion acquisition can help Novartis become the third-largest generic drug company in the US.
  16. Half of Clinical Results Not Published (SNY, NVS)

    November 5, 2016
    Almost of all clinical trials are never published, and this hurts patients by withholding drug information.
  17. New CAR-T Cell Therapy May Cure Tumors (JUNO, KITE)

    October 6, 2016
    Novartis partner University of Pennsylvania has identified a new possibility to treat solid tumors with CAR-T therapy.
  18. Friends or Foes: Amgen and Novartis (AMGN, NVS)

    October 3, 2016
    While the two companies collaborate on developing drugs for migraine and Alzheimer’s disease, they are in a court battle ...
  19. Amgen Maintains Migraine Drug Lead (AMGN)

    September 29, 2016
    Amgen leads the migraine drug race by being the first company to publish phase 3 results, but intense competition looms in ...
  20. Top 6 Pharmaceutical Companies Globally

    August 23, 2016
    Johnson & Johnson leads the pack in both market cap and revenue.
  21. Who Is Driving Novarti's Management Team? (NVS, BAYRY)

    August 12, 2016
    A number of key executives keep the Switzerland-based pharmaceutical firm Novartis moving forward in the development of health ...
  22. The Impact of Novartis' New Business Model (NVS)

    May 23, 2016
    Amid the exit of its U.S. business head, Novartis is splitting its pharma business. Here's a look at what this split means ...
  23. The Top 5 Johnson & Johnson Shareholders (JNJ)

    May 23, 2016
    Learn about the origins of Johnson & Johnson as the company turns 130 and the health care conglomerate's five largest shareholders.
  24. 3 Catalysts That Will Drive AERI Higher in 2016 (AERI, VRX)

    May 8, 2016
    Read about the key drivers of Aerie Pharmaceuticals' stock price, which has been volatile since the company's IPO.
  25. VASGX: Vanguard LifeStrategy Growth Fund Top 4 Holdings Analysis

    May 6, 2016
    Find out how the Vanguard LifeStrategy Growth Fund has constructed its index-based portfolio for aggressive growth-oriented ...
  26. J&J Loses Second Talcum Powder Cancer Case

    May 4, 2016
    A jury recently ordered Johnson & Johnson to pay $55 million in damages to a woman who claimed that its talcum powder ...
  27. Vanguard Launches 2 Dividend-Oriented International ETFs (VIGI, ...

    May 2, 2016
    Find out about two international dividend ETFs launched by Vanguard in March 2016, patterned after its Dividend Appreciation ...
  28. FEZ vs. IEV: Comparing Europe ETFs

    April 26, 2016
    Discover and compare two European exchange-traded funds. Learn about their purpose, strategy, characteristics and investor ...
  29. The 3 Largest Global ETFs (VEU, ACWI)

    April 7, 2016
    Discover the benefits of the largest global ETFs, including exposure to emerging and developed markets, the full range of ...
  30. The 3 Largest Europe ETFs (HEDJ, VGK)

    April 7, 2016
    Discover the range of investing strategies offered by the three largest Europe equity ETFs, including currency hedging and ...
  31. IEV iShares Europe ETF: Top 5 Holdings

    March 29, 2016
    Discover the top five holdings of the iShares Europe ETF, which come from Switzerland, the United Kingdom and France.
  32. Can Novartis Explain 79,236 "Sham" Events? (NVS)

    March 28, 2016
    Novartis AG has been accused by the U.S. government of engaging in a kickback scheme in which the Swiss drug maker wined ...
  33. 5 Popular European Country ETFs in 2016 (EWG, BAYRY)

    March 23, 2016
    Discover the investment strategies available in five popular European country ETFs for 2016, measured by assets under management, ...
  34. (VEU) Vanguard All World ex-US. ETF: Top 5 Holdings

    March 19, 2016
    Find out which large, multinational companies occupy the first five positions in the Vanguard All World ex-U.S. ETF based ...
  35. 5 Popular U.S. Equity ETFs for 2016 (SPY, AAPL)

    March 16, 2016
    Discover 5 ETFs that investors might use to obtain exposure to portions of the U.S. stock market.
  36. Is Big Pharma Under Pressure in 2016? (JNJ, GSK)

    March 8, 2016
    Find out why large pharmaceutical companies are coming under pressure by investors to break themselves up into smaller companies.
  37. VEU Vs. VT: Comparing Global Equity ETFs

    March 8, 2016
    Compare two of the most widely held ETFs, both offered by Vanguard, that provide investors broad exposure to the global equities ...
  38. Novartis Stock: A Dividend Analysis (NVS)

    January 21, 2016
    Discover a detailed analysis of the dividend policy of Novartis AG, and learn about its financials, growth rates, and dividend ...
  39. How Novartis Probably Has a Cure for What Ails You

    January 21, 2016
    A look at the unparalleled growth of the world's biggest pharmaceutical company: Novartis AG.
  40. Healthcare Stocks: Are These 2016's Best?

    January 13, 2016
    Healthcare stocks aren't likely to hold up as well as you think, but these three stocks could offer resiliency.
  41. VXUS: Vanguard International Stock ETF

    December 27, 2015
    Discover how the Vanguard Total International Stock ETF is managed, and learn which investors may find it suitable as part ...
  42. VEA: Vanguard MSCI EAFE ETF

    December 26, 2015
    Learn more about Vanguard's index-shifting, low-cost and non-U.S. market exchange-traded fund: the FTSE Developed ex U.S. ...
  43. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  44. Aduro's Cancer Drug Creates Biotech Buzz

    October 20, 2015
    Aduro has two proprietary, first-in-class cancer immunotherapy platforms that aim to stimulate robust and durable immune ...
  45. Glaxo in $1 Billion Ofatumumab Deal With Novartis (GSK, NVS)

    August 26, 2015
    In the latest deal between two pharmaceutical majors that clearly like doing business with each other, GlaxoSmithKline (NYSE: ...
  46. Pfizer Stock Is Like An Extended Release Drug

    August 12, 2015
    Pfizer is a leading research-driven pharmaceutical company, but how good is its financial health?
  47. Drugmaker Extraordinaire: How Eli Lilly Grows

    August 7, 2015
    Drugs mean big profits in America. Here's how the country's oldest pharmaceutical firm keeps its toehold in the market.
  48. This Key Amgen Drug Is Setting a Precedent (AMGN, NVS)

    June 8, 2015
    Biotech blue-chip stock Amgen (NASDAQ: AMGN) has practically had its way with Wall Street over the last five years. While ...
  49. Who are Pfizer's (PFE) main competitors?

    May 20, 2015
    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ...
  50. 3 Top Pharma Stocks that Pay Regular Dividends (GSK, AZN)

    May 1, 2015
    The low down on three big name, dividend-paying pharma stocks.
  51. Biogen's Tecfidera Loses Some Luster (BIIB, NVS)

    April 30, 2015
    Since winning FDA approval in 2013, Biogen's (NASDAQ: BIIB) Tecfidera has become the most widely prescribed oral multiple ...
  52. How to Analyze Pharma Stock Fundamentals

    April 23, 2015
    What you need to know about analyzing the fundamentals of pharma stocks.
  53. What are examples of major companies in the drugs sector?

    April 1, 2015
    Identify the major players in the drugs sector, which include many established pharmaceutical companies that have delved ...
  54. How is a Spinoff Worth $100 Billion? See AbbVie

    April 1, 2015
    An in depth look at Abbott Labs spinoff AbbVie and how it became a nearly $100 billion company.
  55. The Future of Big Pharma Stocks

    March 31, 2015
    A look at the future health of big pharma stocks.
  56. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  57. Use This ETF To Trade The Swiss Franc

    January 23, 2015
    Traders were stunned last week when the Swiss National Bank removed the currency peg that tied the value of the Swiss franc ...
  58. Most Powerful And Influential Public Companies In 3 Metrics

    December 9, 2014
    There are many ways to rank the word's most powerful companies. Looking at market value, brand value or sales revenue are ...
  59. How Merck Found Its Way Into Millions Of Medicine Cabinets

    September 15, 2014
    With over $40 billion in revenue from pharmaceutical sales, there's a good chance that you'll be very grateful for one of ...
  60. Taking The Contrarian Approach With European Equities

    July 2, 2013
    Investors continue to shun European equities due to the regions debt issues and economic problems. However, that’s a real ...
  61. Big Pharma Faces 'Pay For Delay' Lawsuits

    June 21, 2013
    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve never heard of pay to delay. Instead of ...
  62. After A Good Run, Novartis Looks Fairly Valued

    June 12, 2013
    Novartis is a well-balanced, high-quality pharma with growth credentials, but also a fair valuation today.
  63. Foreign-Owned American Companies

    December 10, 2012
    Buying American, or investing in American companies, is not as easy as it once was, especially when American companies aren't ...
  64. Nestle Almost Never On Sale

    April 24, 2012
    Nestle has a well-earned reputation for excellence and the Street has long been happy to pay a premium for that performance. ...
  65. It's Time To Invest In Switzerland

    October 19, 2011
    Swiss stocks may offer a more conservative hiding place.
  66. Will Nestle Succeed Where Others Have Failed?

    May 26, 2011
    Nestle is making an interesting step into medical pharmaceuticals and diagnostics.
  67. Has Ingenico Done VeriFone A Favor?

    December 23, 2010
    By rebuffing Danaher, Ingencio may be helping VeriFone.
  68. Is Pfizer What The Doctor Ordered Or Bad Medicine?

    April 30, 2009
    Explore Pfizer, its earnings and its recent acquisition deal.